Safety of vagus nerve stimulation in a patient with bipolar disorder and an implanted cardioverter-defibrillator

Acta Neurologica Scandinavica

Volumn 121, Issue 4, 2010, Pages 285-286

  Muller H ^a   Demling, J H ^a   Schutz P ^a   Weigel, D ^a   Kornhuber, J ^a   Sperling, W ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; LAMOTRIGINE; LITHIUM; LUMAX 340 VR-TXL; MELATONIN AGONIST; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; VALPROIC ACID;

ADULT; BIPOLAR DISORDER; CASE REPORT; DEFIBRILLATOR; ELECTROCONVULSIVE THERAPY; FEMALE; HEART VENTRICLE TACHYCARDIA; HUMAN; LETTER; MANIA; REMISSION; SYNCOPE; VAGUS NERVE STIMULATION;

BIPOLAR DISORDER; DEFIBRILLATORS, IMPLANTABLE; EPILEPSY; HEART; HUMANS; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL; SYNCOPE; TACHYCARDIA, VENTRICULAR; VAGUS NERVE; VAGUS NERVE STIMULATION;

EID: 77749258376     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2010.01328.x     Document Type: Letter

References (4)

1. Cáceres R, Richter J, Säfström K, Landtblom AM. Application of a vagal nerve stimulator in an epilepsy patient with cardiac pacemaker after post-ictal cardiac arrest. Acta Neurol Scand 2009 120 : 139 142.
2. Rush AJ, George MS, Sackeim AH et al. Vagus nerve stimulation (VNS) for treatment-resistant depressions. A multicenter study. Biol Psychiatry 2000 47 : 277 286.
3. Stemper B, Devinsky O, Haendl T, Welsch G, Hilz MJ. Effects of vagus nerve stimulation on cardiovascular regulation in patients with epilepsy. Acta Neurol Scand 2008 117 : 231 236.
4. Nierenberg AA, Alpert JE, Gardner-Schuster EE, Seay S, Mischoulon D. Vagus nerve stimulation: 2-year outcomes for bipolar versus unipolar treatment-resistant depression. Biol Psychiatry 2008 64 : 455 460.